Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease

ConclusionsSerum SLPI levels increased with DKD progression and were associated with clinical parameters of DKD. Moreover, elevated SLPI levels showed potential prognostic value for renal endpoint events in individuals with DKD. These findings validate the results of previous studies on SLPI in patients with DKD and provide new insights into the role of SLPI as a biomarker for the diagnosis and prognosis of DKD that require validation.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research